[MP-202508] Sintilimab (NSCLC)
Last updated 21.01.2026
Project no.:
MP-202508
Report type:
Joint Clinical Assessment, JCA
Status:
Commission work started
Department/Division:
Drug Assessment
Topic:
Cancer
Indication:
Treatment of non-small cell lung cancer in adults
Note:
This Joint Clinical Assessment (JCA) is being conducted in cooperation with the National Institute for value and technology in health (NIHO), Slovakia.
Further background information can be found here: European health technology assessment
| Stage | Date |
|---|---|
| Start | 4th quarter, 2025 |
| voraussichtlicher Abschluss | 4th quarter, 2026 |